Hosted on MSN

BriaCell presents phase 2, phase 3 data on Bria-IMT at SABCS 2025

BriaCell (BCTX) Therapeutics presents positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters at the 2025 San Antonio Breast Cancer Symposium, SABCS, taking place December ...
Nasdaq

Arvinas, Inc. Announces Upcoming Phase 3 Trials for Vepdegestrant and Progress on Multiple Clinical Programs

Arvinas plans Phase 3 trials for vepdegestrant combinations in breast cancer and initiates trials for new Parkinson's disease treatments. Arvinas, Inc. announced its plans to begin two Phase 3 ...
Seeking Alpha

Neumora: Phase 3 MDD Readout In H2-24 Could Get Ball Rolling

Neumora Therapeutics (NMRA) has been able to establish an advanced phase 3 program, which is ultimately going to be composed of several late-stage studies. This is going to be the inclusion of three ...
FiercePharma

Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off

With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 as ...
Seeking Alpha

ProKidney appoints new CEO, updates Phase 3 plans for REACT therapy

ProKidney (NASDAQ:PROK) said Monday that it has appointed a new CEO and plans to update its Phase 3 development program for its cell therapy REACT to focus on patients with advanced chronic kidney ...